Ordinarily resistant to economic ills, health care this time is suffering too. Poor and uninsured patients are most at risk.
Once considered mere substitutes for embryonic cells, re-engineered adult cells are making breakthroughs of their own.
Art and message merged in twentieth-century posters, raising the alarm about contagions from TB to AIDS.
An experimental protocol fools the immune system into accepting a new organ without debilitating drugs. Could it become routine?
A new era for stem cell research, by Peter L. Slavin and David F. Torchiana.
Readers discuss depression, bugs, drugs and natural orifice surgery.
Artists with a certain neurological condition put all their senses to work.
With insomnia drugs yielding bizarre side effects, sleepwalking has wandered back into public consciousness.
How an electrified, 660-pound behemoth became a common diagnostic tool: the ECG.
Thirty years ago, the first test-tube baby made medical history.
Michael G. Fitzsimons, head of the drug-testing program at the Massachusetts General Hospital’s Department of Anesthesia and Critical Care, discusses preventing fallout from addicted physicians.
In an excerpt from his novel Cutting for Stone, Abraham Verghese examines the importance of words of comfort.
Scientists—whether they’re new or experienced, engaged in mainstream or unconventional research—all face stiff competition in getting NIH funding.
Confronted with her son’s diagnoses with three rare diseases, a mother contemplates luck—good and bad.